Safety and Pharmacokinetics (PK) Study of Single Ascending Doses of CVT-427 (Zolmitriptan Inhalation Powder) In Healthy Adults

NCT02609945 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

21

Enrollment

INDUSTRY

Sponsor class

Conditions

Migraine

Interventions

DRUG: zolmitriptan
DRUG: CVT-427 (zolmitriptan inhalation powder),

Sponsor

Acorda Therapeutics